Ripasudil
- Generic Name
- Ripasudil
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C15H18FN3O2S
- CAS Number
- 223645-67-8
- Unique Ingredient Identifier
- 11978226XX
- Background
Ripasudil, as hydrochloride hydrate (K-115), is a specifc Rho-associated coiled-coil containing protein kinase (ROCK) inhibitor used for the treatment of glaucoma and ocular hypertension. It was first approved for treatment in Japan in September 2014. This medication is available in the form of a 0.4% eye drop solution under the brand name Glanatec. Ripasudil is a well tolerated medication that is used when other drugs have been proven to be non-effective or cannot be administered.
- Indication
Ripasudil has been proven to be effective in the twice daily treatment of glaucoma and ocular hypertension. It is currently in studies to be approved for both diabetic retinopathy and diabetic macular oedema.
- Associated Conditions
- Ocular Hypertension, Open Angle Glaucoma (OAG)
- Associated Therapies
- -
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.